Literature DB >> 18665415

Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal.

Sophie Alloul1, Nagib Dahdah, Joaquim Miró.   

Abstract

This report describes the rapid buildup of an intraluminal thrombus and secondary myocardial ischemia after a brief therapeutic withdrawal of warfarin in a case of Kawasaki-related chronic giant coronary aneurysm. The importance of tight antithrombotic control in such cases is underscored.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18665415     DOI： 10.1007/s00246-008-9290-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  12 in total

1.  Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease.

Authors:  E Tsuda; T Kamiya; Y Ono; K Kimura; K Kurosaki; S Echigo
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

2.  Steady flow in an aneurysm model: correlation between fluid dynamics and blood platelet deposition.

Authors:  D Bluestein; L Niu; R T Schoephoerster; M K Dewanjee
Journal:  J Biomech Eng       Date:  1996-08       Impact factor: 2.097

Review 3.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Review of the rebound phenomenon in new anticoagulant treatments.

Authors:  Cedric Hermans; Donald Claeys
Journal:  Curr Med Res Opin       Date:  2006-03       Impact factor: 2.580

5.  Mortality among persons with a history of Kawasaki disease in Japan: the fifth look.

Authors:  Yosikazu Nakamura; Hiroshi Yanagawa; Kensuke Harada; Hirohisa Kato; Tomisaku Kawasaki
Journal:  Arch Pediatr Adolesc Med       Date:  2002-02

6.  Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Authors:  Nick R Bijsterveld; Arno H Moons; Joost C M Meijers; Jan G P Tijssen; Harry R Büller; Marcel Levi; Ron J G Peters
Journal:  J Am Coll Cardiol       Date:  2002-03-06       Impact factor: 24.094

7.  Prognostic implications of warfarin cessation after major trauma: a population-based cohort analysis.

Authors:  Daniel G Hackam; Alexander Kopp; Donald A Redelmeier
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

8.  Effect of treatment with low-dose warfarin-aspirin on activated factor VII.

Authors:  G E Raskob; S S Durica; J H Morrissey; W L Owen; P C Comp
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

9.  Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients.

Authors:  L Grip; M Blombäck; S Schulman
Journal:  Eur Heart J       Date:  1991-11       Impact factor: 29.983

10.  Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.

Authors:  Yoko Sugahara; Masahiro Ishii; Hiromi Muta; Motofumi Iemura; Toyojiro Matsuishi; Hirohisa Kato
Journal:  Pediatr Cardiol       Date:  2007-11-20       Impact factor: 1.655
View more
  2 in total

1.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

Review 2.  Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery: case report and literature review.

Authors:  Gabriella De Rosa; Maria Giuseppina Cefalo; Riccardo Marano; Marco Piastra; Angelica Bibiana Delogu; Donato Rigante
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.